L18 & 19 - NSAIDs Flashcards

1
Q

Explain how arachidonic acid is released from the membranes

A

Released from membrane phospholipids by phospholipase A2 (PLA-2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the physiological effect of PGE-2 on blood vessels?

A

dilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the physiological effect of PGF-2a on blood vessels?

A

constriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the physiological effect of PGI-2 on blood vessels?

A

dilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the physiological effect of TXA-2 on blood vessels?

A

constriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the physiological effect of PGI-1 on platelets?

A

inhibition of aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the physiological effect of TXA-2 on platelets?

A

promotion of aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the physiological effect of PGE-2 on bronchi?

A

dilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the physiological effect of PGF-2a on bronchi?

A

constriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the physiological effect of PGE-2 on the uterus?

A

oxytocic dilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the physiological effect of PGF-2a on the uterus?

A

oxytocic constriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

List the end products of the cyclooxygenase pathways

A

Prostaglandins (“PG”)
Thromboxanes (“TX”)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

List the end products of the lipoxygenase pathways

A

Leukotrienes
Also - HPETEs, Lipoxins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

List the effects of COX-1 inhibition

A

GI effects
- Stomach irritation & ulceration
- Blockade of platelet aggregation
- Inhibition of uterine motility
- Inhibition of PG-mediated renal function
- Hypersensitivity reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

List the effects of COX-2 inhibition

A
  • Pain relief
  • Elevated blood pressure
  • Accelerated atherogenesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe Alprostadil

A

a therapeutic prostaglandin

  • PGE-1
  • Relaxes smooth muscles and expand blood vessels
  • Used for erectile dysfunction by injection or as a suppository
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe misoprostol

A

a therapeutic prostaglandin

  • PGE-1 derivative
  • Cytoprotective
  • Prevents peptic ulcer, terminates early pregnancy in combination with mifepristone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe latanoprost

A

a therapeutic prostaglandin

  • topically active PGF-2a derivative (prodrug)
  • constricts blood vessels
  • used in ophthalmology to treat high pressure inside eye (ex. glaucoma)
19
Q

Describe prostacyclin

A

a therapeutic prostaglandin

  • PGI-2
  • Powerful vasodilator, inhibitor of platelet aggregation
  • Used to treat pulmonary arterial hypertension by IV injection or inhalation
    (shouldn’t be used with anticoagulants)
20
Q

List the pharmacological activities of NSAIDs

A

Anti-inflammatory
Analgesic → pain killing
Antipyretic → fever suppressant

21
Q

Explain the mechanism of action of NSAIDs

A

Inhibition of prostaglandin endoperoxide H synthase (PGHS or COX), which catalyzes the formation of prostaglandins
(Many NSAIDs inhibit both COX-1 and COX-2)

22
Q

Explain the mechanism of gastric bleeding caused by NSAIDs

A
  • Primary insult → acidity of many NSAIDs
  • Secondary insult → Inhibition of synthesis of cytoprotective prostaglandins (PGEs) in gastric mucosa
  • There is also an inhibition of platelet aggregation → causes increased tendency of bleeding
23
Q

Explain the mechanism of the inhibition of blood coagulation by aspirin

A

Irreversible inhibition of platelet COX-1 and the consequent reduced formation of thromboxane

24
Q

What is Reye’s syndrome?

A
  • A rare, acute, life-threatening condition characterized by vomiting, delirium, and coma
  • Brain damage is common in survivors
25
Q

What is one of the causes of Reye’s syndrome?

A

giving salicylates (aspirin) to children who have had the chicken pox or flu

26
Q

Who should aspirin NOT be given to?

A

anyone under the age of 12 who has a fever

27
Q

Explain the main cause of drug interactions of NSAIDs

A

NSAIDs compete with other drugs for serum albumin binding sites (ex oral anticoagulants)

28
Q

List the classes of NSAIDs

A

Salicylates
Arylacetic acids
Arylpropionic acids
Non-carboxylate NSAIDs
COX-2 selective NSAIDs

29
Q

Explain the role of α-methyl group in the structure-activity relationship of arylpropionic acids

A

The α-Methyl group enhances it activity and reduces many side effects

30
Q

Describe the difference in the mechanism of action of acetaminophen from that of NSAIDs

A

It does not inhibit arachidonic acid binding to PGHS

31
Q

What is the mechanism of action of acetaminophen?

A
  • Prevents PGH synthase activity by scavenging for Peroxynitrite, the major oxidant for PGH synthase activity in the CNS
  • In inflammation, high concentrations of peroxides are present, and acetaminophen scavenging is overwhelmed
32
Q

List NSAIDs that are prodrugs

A

Sulindac
Nabumetone (non-acidic)

33
Q

How is Sulindac converted to its active metabolite?

A

the sulfoxide group is reduced to the active sulfide intermediate in the circulatory system

34
Q

How is Nabumetone converted to its active metabolite?

A

Metabolized rapidly to 6-methoxynaphthalene-acetic acid (6-MNA), which is an effective inhibitor of COX

35
Q

Explain the structural basis of selective COX-2 inhibitors

A
  • Selective COX-2 inhibitors exploit the larger NSAID binding site in COX-2 (valine) with larger and relatively rigid substituents
  • Prevented from binding to COX-1 because of the smaller isoleucine binding site
36
Q

Describe the mechanism of elevated blood pressure caused by selective COX-2 inhibitors

A
  • Constitutive expression of COX-2 in endothelium is critical for production of PGI-2 (prostacyclin)
  • High PGI-2 production → dilation of blood vessels & inhibited aggregation of platelets
37
Q

Describe the mechanism of accelerated atherogenesis caused by selective COX-2 inhibitors

A
  • Selective COX-2 inhibitors do not affect the production of TXA-2 by COX-1; heightened thrombotic response on the rupture of atherosclerotic plaque
  • Lower levers of TXA-2 → no constriction to combat dilation, no aggregation being promoted
38
Q

List the side effects of selective COX-2 inhibitors

A

elevated blood pressure
accelerated atherogenesis

39
Q

List examples salicylates

A

Salicylic acid
Aspirin
Salsalate (Disalcid)
Diflunisal (Dolobid)

40
Q

List examples of arylacetic acids

A

Indomethacin (Indocin, Tivorbex)
Sulindac (Clinoril)
Etodolac (Lodine)
Diclofenac (Cataflam, Voltaren)

41
Q

List examples of non-carboxylates

A

Nabumetone (Relafen)
Meloxicam (Mobic, Vivlodex)

42
Q

List examples of COX-2 selective inhibitors

A

Celecoxib (Celebrex)

43
Q

List examples of eicosanoid drugs

A

Alprostadil (Edex)
Misoprostol (Cytotec)
Latanoprost (Xalatan, Monopost)
Prostacyclin (Epoprostenol)